Security key
293602405
Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC)
CUSIP: 293602405
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 52,722
- Total 13F value
- $56,026
- Share change
- -114,969
- SEC-reported price per share
- $1.06
- Number of holders
- 7
- Value change
- -$163,127
- Number of buys
- 4
- Number of sells
- 7
- Shares outstanding
- 19,603,857
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
7
Top holders
7
ENSC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Ensysce Biosciences, Inc. SEC filings
Ensysce Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 293602405
Recent filing periods:
Ownership snapshot
Top reported holders of ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
A. Lorne Weil
Comparable rows
11/15
Latest evidence
30 Sep 2023
13F
3/4/5
Lead comparable stake: 0.49%
4 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 0.49%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SABBY MANAGEMENT, LLC
0.49%
CITADEL ADVISORS LLC
0.1%
GEODE CAPITAL MANAGEMENT, LLC
0.08%
VANGUARD GROUP INC
0.08%
TWO SIGMA SECURITIES, LLC
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
0.49%
|
$133,823
96,973 shares
|
— | 30 Sep 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.1%
|
$26,185
19,113 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.08%
|
$22,509
16,430 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.08%
|
$21,278
15,419 shares
|
— | 30 Sep 2023 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.07%
|
$20,170
14,616 shares
|
— | 30 Sep 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.02%
|
$5,418
3,926 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
52,722
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
11
Q4 2023 holders
7
Holder diff
-4
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend